Figure 4.
Cumulative incidence of hemorrhagic events in all patients. Five-year incidence rates for antiplatelet therapy (dotted line) and no antiplatelet therapy (solid line) were 23.1% and 21.4%, respectively (p = 0.33).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.